Similar articles

• A study of the hematological side effects of levamisole in rheumatoid arthritis with recommendations.

  Mielants H, Veys EM. Mielants H, et al. J Rheumatol Suppl. 1978;4:77-83. J Rheumatol Suppl. 1978. PMID: 282448
• B27 and agranulocytosis in rheumatoid arthritis patients treated with levamisole.

  Mielants H, Veys EM. Mielants H, et al. Acta Rhumatol. 1979 Apr-Jun;3(2):104-7; discussion 107-9. Acta Rhumatol. 1979. PMID: 11496648 No abstract available.
• Agranulocytosis, levamisole, and HLA-B27.

  Veys EM, Mielants H, Rosenthal M. Veys EM, et al. Lancet. 1977 Oct 8;2(8041):764. doi: 10.1016/s0140-6736(77)90270-7. Lancet. 1977. PMID: 71571 No abstract available.
• Adverse reactions to levamisole.

  Symoens J, Veys E, Mielants M, Pinals R. Symoens J, et al. Cancer Treat Rep. 1978 Nov;62(11):1721-30. Cancer Treat Rep. 1978. PMID: 365327 Review.
• [Rheumatoid arthritis and the HLA system].

  Sheĭtanov I. Sheĭtanov I. Vutr Boles. 1984;23(2):44-7. Vutr Boles. 1984. PMID: 6377703 Review. Bulgarian. No abstract available.